乳腺癌血清生物标志物的生物信息学分析和实验验证
Bioinformatics analysis and experimental verification of serum biomarkers of breast cancer
近年来,乳腺癌发病率逐年上升,其发病率和死亡率居女性恶性肿瘤首位。研究早期诊断生物标志物至关重要。方法:本研究中,以GEO数据库中获得的三个数据集进行生物信息学分析,以鉴定乳腺癌相关的差异表达基因(DEGs)。同时结合RT-qPCR技术,验证获得的基因作为潜在靶标的可能性。结果:通过使用蛋白质 - 蛋白质相互作用(PPI)网络分析,基因本体(GO)和基因和基因组京都百科全书(KEGG)途径,本研究选择BLK和miR-4251、miR-3135b以及FCRLA和miR-1273a做进行进一步研究,发现相较于对照组,乳腺癌患者血清中BLK和FCRLA呈现上调趋势,而miR-4251、miR-3135b和miR-1273a呈现下调趋势,均有统计学意义。结论:本研究发现的关键基因可能与乳腺癌的诊断和预后相关,该结果为乳腺癌的机制研究提供新的参考意义。
In recent years, the incidence of breast cancer has increased with years, and its morbidity and mortality rate are the first in female malignant tumors. It is essential to study early diagnostic biomarkers. Methods: In this study, bioinformatics analysis were performed on three data sets obtained in the GEO database to identify differentially expressed genes (DEGs) associated with breast cancer. The obtained gene is simultaneously combined with the RT-qPCR technology to verify the possibility of serving as a potential target. Results: By using protein-protein interaction (PPI) network analysis, the Gene Ontology (GO) and Gene and Genome Kyoto Encyclopedia (KEGG) pathways, BLK and MIRI-4251, MIRI-3135B, and FCRLA and MIRI-1273A were selected for further study. It was found that compared with the control group, BLK and FCRLA in serum of breast cancer patients showed an upward trend, while MIRI-4251, MIRI-3135B and MIRI-1273A showed a downward trend, all of which were statistically significant. Conclusion: The key genes identified in this study may be related to the diagnosis and prognosis of breast cancer, which will provide new reference for the mechanism research of breast cancer.
宗旭敏、高锦、崔凤梅、涂彧
肿瘤学基础医学生物科学研究方法、生物科学研究技术
乳腺癌生物标志物生信分析
breast cancerbiomarkersbioinformatics analysis
宗旭敏,高锦,崔凤梅,涂彧.乳腺癌血清生物标志物的生物信息学分析和实验验证[EB/OL].(2023-05-10)[2025-09-04].http://www.paper.edu.cn/releasepaper/content/202305-31.点此复制
评论